Clik here to view.
Biogen twisting data to get patients to switch to more expensive MS medication?
KEY TAKEAWAY: What happens when a drug company presents “select” data to try and get patients to switch to a more expensive oral therapy? Jennifer, an MS patient, recently moved from the Midwest to the...
View ArticleClik here to view.
Biogen moves the goal posts
Eisai and Biogen posted promising data for BAN2401 that lifted its stock and had the pharma trade publications talking breakthrough. But there is a lot of controversy swirling around the study. It...
View ArticleClik here to view.
Biogen dupes us all
KEY TAKEAWAY: “We still believe that amyloid beta hypothesis is potentially the right approach for the treatment of Alzheimer’s disease,” an Eisai spokesman told Reuters. What made Wall Street and...
View ArticleClik here to view.
The debate on Biogen’s AZ drug
WHAT ARE PEOPLE SAYING: STAT news article “I used to work on Biogen’s Alzheimer’s drug. Is the company spinning bad data?” is generating quite a debate. Some people support Biogen’s submission of the...
View ArticleClik here to view.
Biogen comes under fire
SUMMARY: Endpoints and STAT news are reporting that Biogen is coming under intense scrutiny when it comes to their failed drug aducanumab. According to the Endpoints report “On Monday Baird’s Brian...
View ArticleClik here to view.
Biogen’s Alzheimer’s drug: What’s the price tag on hope?
SUMMARY: The FDA is coming under intense pressure to approve Biogen’s Alzheimer’s drug, but Aaron S. Kesselheim, a professor of medicine at Harvard Medical School via the Washington Post, says “the...
View ArticleClik here to view.
Biogen is in deep trouble and may not survive
SUMMARY: The Committee on Oversight and Reform and the Committee on Energy and Commerce is investigating the approval process for Biogen’s new Alzheimer’s drug.Janet Woodcock acknowledged on Wednesday...
View ArticleClik here to view.
Biogen: This train wreck was due
MY POINT: Success is always temporary. When all is said and one, the only thing you’ll have left is your character. Right now, I could make a great argument that Biogen’s character is trashed and that...
View ArticleClik here to view.
Biogen continues to sink
Board members and senior executives are bailing out of Biogen but will there be enough life vests? What has/is happening at Biogen is a train wreck, and the only way to correct this disaster is to tear...
View ArticleClik here to view.
Biogen: It’s a cruel business world
Biogen announced that CEO Michel Vounatsos is being replaced as the big biotech undergoes a restructuring of the pipeline. It’s long overdue but kind of like putting smoke detectors in a house...
View Article
